Pallidal border cells: An anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

Neuroscience

Volumn 103, Issue 1, 2001, Pages 117-123

  Bezard, E ^a,b   Boraud, T ^b   Chalon, S S ^c   Brotchie, J M ^a   Guilloteau, D D ^c   Gross, C E ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

Dopamine transporter; Levodopa; Pallidum; Parkinson's disease; Single unit recordings

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; LEVODOPA; RADIOLIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CELL SUBPOPULATION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; GLOBUS PALLIDUS; LIGAND BINDING; MONKEY; NERVE CELL STIMULATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPARKINSON AGENTS; CARRIER PROTEINS; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROPHYSIOLOGY; FEMALE; GLOBUS PALLIDUS; LEVODOPA; MACACA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PARKINSON DISEASE, SECONDARY; RADIOLIGAND ASSAY;

EID: 0035961219     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00546-7     Document Type: Article

References (49)

1. Intercellular communication in the brain: Wiring versus volume transmission
2. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing
3. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism
4. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms
5. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: Evolution of motor symptoms in the monkey
6. Experimental models of Parkinson's disease: From the static to the dynamic
7. Adaptive changes in nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse
8. High frequency stimulation of the internal globus pallidus reduces the higher firing frequency of its neurons in the MPTP-treated monkey model of Parkinson's disease
9. The ratio of inhibited to activated pallidal neurons decreases dramatically during passive limb movements in the MPTP-treated monkey
10. Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey
11. Effects of riluzole on the electrophysiological activity of pallidal neurons in the MPTP-treated monkey
12. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease
13. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β- (4′-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter
14. Immunocytochemical localization of the dopamine transporter in human brain
15. The dopamine transporter: Immunochemical characterization and localization in brain
16. Dopamine receptor binding: Enhancement accompanying lesion-induced behavioural supersensitivity
17. Activity of pallidal neurons during movement
18. Synthesis and ligand binding of nortropane derivatives: N-substituted 2β-carboxymethoxy-3β-(4′-iodophenyl) nortropane and N-(3-iodoprop-2E-enyl)-2β-carboxymethoxy-3β-(3′,4′- disubstituted phenyl) nortropane: New high-affinity and selective compounds for the dopamine transporter
19. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced Parkinsonism
20. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced Parkinsonism
21. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in Parkinson's disease
22. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals
23. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
24. Tyrosine-hydroxylase-containing neurons in the primate basal forebrain magnocellular complex
25. Exploration of the dopamine transporter: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β- (4′-methylphenyl) nortropane (PE2I)
26. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I
27. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat
28. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients
29. Burst and oscillations as disparate neuronal properties
30. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry
31. The basal ganglia: Focused selection and inhibition of competing motor programs
32. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes
33. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D-1 or D-2 receptor agonists
34. Neuronal activity in the primate premotor, supplementary and precentral motor cortex during visually guided and internally determined sequential movements
35. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
36. Chemical anatomy of primate basal ganglia
37. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
38. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry
39. The dopaminergic nigropallidal projection in primates: Distinct cellular origin and relative sparing in MPTP-treated monkeys
40. Differential dopaminergic innervation of the two pallidal segments in the squirrel monkey (Saimiri sciureus)
41. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion
42. Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: Implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology
43. Evidence for a distinct nigropallidal dopaminergic projection in the squirrel monkey
44. 125I]RTI-55: In vitro binding and autoradiographic characterization
45. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis)
46. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat
47. A Golgi analysis of the primate globus pallidus. II. Quantitative morphology and spatial orientation of dendritic arborizations
48. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications
49. Wiring and volume transmission in the central nervous system: The concept of closed and open synapses